GLIS2 promotes colorectal cancer through repressing enhancer activation
GLIS2 promotes colorectal cancer through repressing enhancer activation
复制标题
GLIS2通过抑制增强子激活促进结直肠癌
DOI:
10.1038/s41389-020-0240-1
复制
发表时间:
2020
期刊:
影响因子:
6.2
通讯作者:
Min Wu
中科院分区:
文献类型:
--
作者:
Jie Yao;Pin-Ji Lei;Qing-Lan Li;Ji Chen;Shan-Bo Tang;Qiong Xiao;Xiang Lin;Xiang Wang;Lian-Yun Li;Min Wu
Gene transcription is coordinately regulated by multiple transcription factors. However, a systematic approach is still lacking to identify co-regulators for transcription factors. Here, we performed ChIP-Seq analysis and predicted the regulators for p53-mediated transcription process, from which we confirmed the roles of GLIS2, MAZ and MEF2A in regulating p53 target genes. We revealed that GLIS2 selectively regulates the transcription ofPUMAbut notp21. GLIS2 deficiency caused the elevation of H3K27ac and p53 binding on thePUMAenhancer, and promotedPUMAexpression. It increased the rate of apoptosis, but not cell cycle. Moreover, GLIS2 represses H3K27ac level on enhancers, regulates the gene expression related with focal adhesion and promotes cell migration, through inhibiting p300. Big data analysis supportsGLIS2as an oncogene in colon cancer, and perhaps other cancers. Taken together, we have predicted candidates for p53 transcriptional regulators, and provided evidence forGLIS2as an oncogene through repressing enhancer activation.